ELISA 검사 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 방법별, 용도별, 기술별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

The Global ELISA Test Market, valued at USD 2.49 Billion in 2024, is projected to experience a CAGR of 7.84% to reach USD 3.92 Billion by 2030. The Enzyme-Linked Immunosorbent Assay (ELISA) is a biochemical technique primarily employed for detecting and quantifying soluble substances such as peptides, proteins, antibodies, and hormones in biological samples. The global ELISA test market's expansion is significantly driven by the escalating prevalence of infectious and chronic diseases, including conditions like HIV and various cancers, which necessitate accurate and timely diagnostic tools. Furthermore, continuous advancements in diagnostic technology, enhancing the sensitivity, specificity, and automation of ELISA assays, contribute substantially to market growth.

Key Market Drivers

The global ELISA Test Market is significantly shaped by the escalating prevalence of infectious and chronic diseases, driving a persistent need for accurate and timely diagnostic solutions. The burden of such conditions necessitates widespread testing, with ELISA assays playing a crucial role in disease surveillance and management. For instance, according to the World Health Organization, as of 30 April 2024, over 7.6 million dengue cases were reported globally in 2024, demonstrating the continuous demand for effective diagnostic tools to monitor and control infectious disease outbreaks. This growing disease landscape directly increases the volume of diagnostic procedures required, thereby expanding the market for ELISA tests globally.

Key Market Challenges

High initial investment costs for advanced ELISA equipment and reagents represent a significant challenging factor in the global ELISA test market. The substantial capital expenditure required for acquiring and maintaining sophisticated ELISA systems can limit the adoption of these diagnostic tools, particularly in healthcare settings with restricted budgets. This directly impedes market growth by creating a barrier to entry for smaller laboratories and those in developing regions. For instance, according to a 2024 Lab Manager Industry and Equipment Trends Survey, 55 percent of respondents cited investment in tools, equipment, and instruments as a top challenge, with 64 percent noting difficulty in securing budget approval for new technology. These financial constraints often force laboratories to extend the lifespan of older, less efficient equipment or forgo advanced automation, impacting their capacity for high-throughput testing and the adoption of newer, more sensitive ELISA assays.

Key Market Trends

Miniaturization and Point-of-Care ELISA Platforms are significantly transforming the global ELISA test market by expanding diagnostic accessibility and speeding up result delivery in various settings. This trend facilitates testing closer to patients, moving beyond traditional centralized laboratories and enabling more immediate clinical decisions. The American Association for Clinical Chemistry (AACC) notably underscored the growing importance of decentralized diagnostic solutions by featuring point-of-care as a key topic at its 2023 Annual Scientific Meeting, encompassing a range of cutting-edge diagnostic tests. This strategic shift responds to the demand for rapid, on-site diagnostics that improve patient management, particularly for conditions requiring frequent monitoring or swift intervention. Abbott, a leading diagnostics company, demonstrated advancements in its point-of-care portfolio, with its second-quarter 2024 results highlighting strong demand for rapid diagnostics used for respiratory diseases, often utilizing compact, near-patient platforms. These advancements are critical for the broader adoption of ELISA technologies in diverse healthcare environments.

Key Market Players

• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• bioMerieux India Private Limited
• Enzo Biochem Inc.
• BioLegend, Inc.
• ELISA Technologies, Inc.
• RayBiotech, Inc.
• Eurofins Scientific (Ireland) Limited

Report Scope:

In this report, the Global ELISA Test Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

ELISA Test Market, By Method:

• Direct ELISA
• Indirect ELISA
• Sandwich ELISA
• Competitive ELISA

ELISA Test Market, By Application:

• Vaccine Development
• Immunology
• Diagnostics
• Toxicology
• Drug Monitoring and Pharmaceutical Industry
• Transplantation
• Others

ELISA Test Market, By Technology:

• Chemiluminescent
• Colorimetric
• Fluorescent

ELISA Test Market, By End User:

• Hospitals
• Diagnostic Centers
• Research Laboratories
• Others

ELISA Test Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global ELISA Test Market.

Available Customizations:

Global ELISA Test Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global ELISA Test Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Method (Direct ELISA, Indirect ELISA, Sandwich ELISA, Competitive ELISA)
  • 5.2.2. By Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring and Pharmaceutical Industry, Transplantation, Others)
  • 5.2.3. By Technology (Chemiluminescent, Colorimetric, Fluorescent)
  • 5.2.4. By End User (Hospitals, Diagnostic Centers, Research Laboratories, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America ELISA Test Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Method
  • 6.2.2. By Application
  • 6.2.3. By Technology
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States ELISA Test Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Method
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Technology
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada ELISA Test Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Method
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Technology
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico ELISA Test Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Method
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Technology
      • 6.3.3.2.4. By End User

7. Europe ELISA Test Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Method
  • 7.2.2. By Application
  • 7.2.3. By Technology
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany ELISA Test Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Method
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Technology
      • 7.3.1.2.4. By End User
  • 7.3.2. France ELISA Test Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Method
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Technology
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom ELISA Test Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Method
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Technology
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy ELISA Test Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Method
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Technology
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain ELISA Test Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Method
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Technology
      • 7.3.5.2.4. By End User

8. Asia Pacific ELISA Test Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Method
  • 8.2.2. By Application
  • 8.2.3. By Technology
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China ELISA Test Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Method
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Technology
      • 8.3.1.2.4. By End User
  • 8.3.2. India ELISA Test Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Method
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Technology
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan ELISA Test Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Method
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Technology
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea ELISA Test Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Method
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Technology
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia ELISA Test Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Method
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Technology
      • 8.3.5.2.4. By End User

9. Middle East & Africa ELISA Test Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Method
  • 9.2.2. By Application
  • 9.2.3. By Technology
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia ELISA Test Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Method
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Technology
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE ELISA Test Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Method
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Technology
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa ELISA Test Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Method
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Technology
      • 9.3.3.2.4. By End User

10. South America ELISA Test Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Method
  • 10.2.2. By Application
  • 10.2.3. By Technology
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil ELISA Test Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Method
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Technology
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia ELISA Test Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Method
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Technology
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina ELISA Test Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Method
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Technology
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global ELISA Test Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. F. Hoffmann-La Roche Ltd.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Thermo Fisher Scientific, Inc.
• 15.3. Becton, Dickinson and Company
• 15.4. Bio-Rad Laboratories, Inc.
• 15.5. bioMerieux India Private Limited
• 15.6. Enzo Biochem Inc.
• 15.7. BioLegend, Inc.
• 15.8. ELISA Technologies, Inc.
• 15.9. RayBiotech, Inc.
• 15.10. Eurofins Scientific (Ireland) Limited

16. Strategic Recommendations

17. About Us & Disclaimer